Stanford’s Russ Altman and Jennifer Cochran examine the “renaissance” in cancer treatment that uses biochemical “guided missiles” to target malignant cells in the body.
By Stanford Engineering Staff
For years, cancer treatment was confined to three flawed strategies. You could cut it out with a scalpel, you could burn it out with radiation, or you could kill it with chemicals. “Today, we are amid a renaissance in cancer treatment,” says Stanford bioengineer Jennifer Cochran. “We are creating designer proteins and using them to deliver drugs or to harness the immune system to help stop this killer dead in its tracks.”